Pawel Zolnierczyk

Pawel is co-founder and Chief Executive Officer of iQure Pharma Inc. A physicist and business manager by training, Pawel is a driven entrepreneur who successfully set-up and managed the oncology-focused university spin-off Onco-NX Ltd, which was sold in 2014. Pawel successfully managed new therapeutics and diagnostics inventions including exits via license to global pharma with a commercial value of tens of millions of dollars. Pawel raised over $12M for early-stage companies from Business Angels, Venture Capital, and Charity organizations. Between 2014 and 2018, Pawel served as IP and R&D Manager and later as the Chief Operating Officer in UK based oncology-focused company Incanthera Plc. During this time, he was responsible for portfolio management of over 100 patents and 4 new therapeutics drugs in preclinical and early clinical stages of development. Pawel is a graduate of the Gdansk University of Technology (PL) – Physics and The University of Salford (UK) – Master of Enterprise Technology (Hons).